Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 4 3Phase 2 1Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Pain 3Malignant Female Reproductive System Neoplasm 2Rectal Neoplasms 1Pulmonary Nodule 1Pain, Postoperative 1Neoplasms 1Ileus 1Hematologic Neoplasms 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Cancer Pain 1Agnosia 1

Interventions

Fentanyl 9Acetaminophen 5Zoledronic Acid 4Oxycodone 4Ketamine 4Bupivacaine 4Sufentanil 3Hydromorphone 3Diclofenac 3Ropivacaine 2Pregabalin 2Morphine 2Ketorolac 2Ibuprofen 2Ibandronic Acid 2Esketamine 2Epinephrine 2naloxegol 1chloroprocaine 1acetaminophen, aspirin, caffeine drug combination 1Varenicline 1Uterine Artery Embolization 1Ultracet 1Therapeutics 1Propofol 1Pamidronate 1Oxygen 1Nitrous Oxide 1Naproxen 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Pain × Hydromorphone × Clear all
NCT01812759 2021-06-29

Fentanyl for Breakthrough Pain in the Emergency Department

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 8 charts

Emergencies, Pain

NCT02459964 2021-06-16

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

M.D. Anderson Cancer Center

Phase 4 Completed
84 enrolled 11 charts

Pain

NCT01648699 2013-10-11

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Janssen Pharmaceutica

Phase 4 Terminated
20 enrolled 9 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡